Suzhou Ribo Life Science’s $40 Million Series E1 Financing Round

Kirkland & Ellis advised Suzhou Ribo Life Science Co., Ltd. on the transaction.Suzhou Ribo Life Science Co., Ltd. (Ribo), a clinical stage company developing innovative RNAi…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now